AMANTA NSE filing

Amanta Healthcare Q2 FY27 Results: Income ₹5712 Cr, Net Profit ₹1311 Cr (Consolidated)

The RealCase readMedium impact Positive

Amanta Healthcare reported consolidated Q2 FY27 income of ₹5,712.06 crore and net profit before tax of ₹1,311.29 crore. For the half-year ended September 30, 2026, consolidated income was ₹13,009.01 crore, with net profit before tax at ₹3,750.52 crore. Basic EPS stood at ₹18.57 for the quarter.

Why it matters

The announcement provides key financial metrics for the quarter and half-year, which are important for investors to assess the company's performance and financial health.

The market read

The company has reported strong financial results with significant income and profit figures for the quarter and half-year ended September 30, 2026.

Amanta Healthcare Limited has announced its financial results for the quarter and half-year ended September 30, 2026. The company's Board of Directors approved these results in a meeting held on November 3, 2026. Copies of the newspaper advertisement, published on November 5, 2026, in Business Standard (English) and Jai Hind (Gujarati), are enclosed.

The company reported a Total Income from Operations of ₹5,712.06 crore for the quarter ended September 30, 2026. The Net Profit Before Tax (including exceptional items) stood at ₹1,311.29 crore for the same period. For the half-year ended September 30, 2026, Total Income from Operations was ₹13,009.01 crore, with a Net Profit Before Tax of ₹3,750.52 crore.

On a consolidated basis, Total Income from Operations for the quarter was ₹5,712.06 crore, and Net Profit Before Tax was ₹1,311.29 crore. For the half-year ended September 30, 2026, consolidated Total Income from Operations was ₹13,009.01 crore, and Net Profit Before Tax was ₹3,750.52 crore.

Basic Earnings Per Share (EPS) for the quarter ended September 30, 2026, was ₹18.57 (standalone) and ₹18.57 (consolidated). Diluted EPS for the same period was ₹18.38 (standalone) and ₹18.38 (consolidated).

The financial results are also available on the company's website, www.amanta.co.in, in compliance with Regulation 46 of the Listing Regulations.

Filing to action

What to do with a filing like this

Amanta Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Amanta Healthcare Limited. Read the original for the full detail.

View original filing